Abstract
Lymphogranuloma venereum (LGV) is a sexual transmitted infection (STI), currently endemic within the population of men who have sex with men (MSM) of Western Countries. L2B variant has been reported as the predominant strain in the current LGV epidemics, although a shift towards L2-434 has been observed in some European countries. To evaluate and characterize the population with LGV infection diagnosed in Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal. A retrospective analysis of all LGV diagnoses between 2016 and 2019 was performed. The diagnosis was established through ompA-genotyping of samples yielding a positive result to Chlamydia trachomatis (CT). All considered samples were retrieved from the clinician activity, through swabbing and urine analysis and CT infection diagnosis was obtained using real-time PCR. During the period studied 16279 CT diagnostics tests were employed, with a striking increase from 2016 (n=467) to 2019 (n=9362). A total of 1602 diagnoses of CT were established, from which 168 (10.5%) corresponded to LGV, with both infections showing a rising evolution, between 2016 and 2019, of 2.9 and 2.7 times, respectively. The majority of the LGV strains were genotyped as L2/434 (67.3%; n=113). LGV predominantly affected MSM and men who have sex with men and women (97.0%; n=163). Anorectal infection was the most prevalent one (90.5%; n=152), being proctitis the main clinical presentation (76.2%; n=128). Absence of symptoms was reported in almost 15% of the cases (n=24). The presence of concomitant infection with human immunodeficiency virus was dominant (73.2%; n=123) and the prevalence of one or more STI co-infections was about 60.1% (n=99). An increasing evolution of CT and LGV testing and diagnosing was observable throughout the studied period. Characteristics of the population are similar with those described within LGV epidemics. In accordance with recent European studies, predominance towards L2 genotype was identified.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the European Academy of Dermatology and Venereology : JEADV
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.